Skip to main content
. 2019 Apr;10(2):300–306. doi: 10.21037/jgo.2018.11.08

Table 6. Stage-specific overall survival for goblet cell carcinoids.

Overall survival Stage I Stage II Stage III Stage IV
1-year OS 100% 95.9% 89.1% 85.7%
2-year OS 96.6% 95.2% 89.1% 44.9%
3-year OS 96.6% 91.7% 65.3% 32.9%
4-year OS 87.9% 88.2% 65.3% 32.9%